Does inflammation reduce peripheral T4→T3 conversion and lower T3 levels?

Systemic inflammation and the release of pro-inflammatory cytokines are well-established drivers of reduced peripheral T4 to T3 conversion, leading to lower serum T3 levels—a state often characterized as non-thyroidal illness syndrome (NTIS).

Clinical and mechanistic evidence

Research across diverse medical contexts, including sepsis, acute myocardial infarction, and COVID-19, consistently shows a significant inverse correlation between inflammatory markers and thyroid hormone levels.

• Correlation with markers: Free T3 (FT3) levels exhibit a strong negative correlation (r ≈ –0.41) with C-reactive protein (CRP) and Interleukin-6 (IL-6). Higher systemic inflammation is reliably associated with lower circulating T3.
• Deiodinase suppression: Pro-inflammatory cytokines, specifically IL-6, TNF-alpha, and IL-1beta, reduce the peripheral conversion of T4 to T3. They achieve this by transcriptionally repressing the DIO1 and DIO2 genes, which encode Type 1 and Type 2 deiodinases—the enzymes responsible for T3 production in the liver, kidney, and muscle.
• Enzyme degradation and oxidative stress: Beyond gene expression, inflammation triggers the post-translational degradation of the D2 enzyme via ubiquitination. Furthermore, cytokine-driven oxidative stress oxidizes the thiol cofactors required for deiodinase activity, directly impairing enzyme function even if the protein levels are normal.
• Metabolic shunting: Inflammation actively induces Type 3 deiodinase (D3), an enzyme that inactivates thyroid hormones. This shifts the metabolic pathway from producing active T3 to producing inactive reverse T3 (rT3) and T2, further depleting T3 pools.

Clinical implications

This reduction in T3 is generally considered an adaptive metabolic response to illness rather than a primary thyroid disorder.

• Resolution: T3 levels typically normalize as the underlying inflammatory state or acute illness resolves.
• Diagnostic insight: In patients with systemic inflammation (high CRP or NLR), low T3 levels should be interpreted within the context of NTIS rather than necessarily indicating permanent hypothyroidism.

Bottom line

Strong scientific evidence confirms that inflammation reduces T4 to T3 conversion and lowers overall T3 levels. This occurs through a multi-pronged mechanism: the suppression of activating enzymes (D1/D2), the induction of inactivating enzymes (D3), and oxidative stress that impairs biochemical catalysis.